Acadia Pharmaceutica (ACAD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
14.60 +0.17 (+1.18%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 14.60 unch (unch) 16:22 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ACAD | MLTX | DNLI | ||
| Company | Acadia Pharmaceutica | Moonlake Immunotherapeutics | Denali Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.36 | 40.26 | 16.17 | ||
| High | 14.65 | 42.54 | 16.84 | ||
| Low | 14.18 | 40.24 | 16.17 | ||
| Last | 14.60 | 42.08 | 16.65 | ||
| Change | +0.17 | +1.90 | +0.15 | ||
| % Change | +1.18% | +4.73% | +0.91% | ||
| Volume | 1,863,200 | 466,300 | 1,911,900 | ||
| 20-Day Average Volume | 1,689,410 | 487,860 | 1,677,645 | ||
| Previous Close | 14.43 | 40.18 | 16.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.81 | 37.64 | 13.72 | ||
| 20-Day Raw Stochastic | 36.04% | 95.86% | 96.89% | ||
| 20-Day Relative Strength | 40.08% | 57.59% | 57.35% | ||
| Weighted Alpha | -17.94 | -9.29 | -21.64 | ||
| Today's Opinion | 88% Sell | 56% Sell | 56% Sell | ||
| Previous Opinion | 88% Sell | 64% Sell | 56% Sell | ||
| Last Month's Opinion | 24% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.14% since 04/23/25 | +6.50% since 04/23/25 | +11.97% since 04/23/25 | ||
| Low | 14.18 on 04/30/25 | 38.20 on 04/25/25 | 14.71 on 04/24/25 | ||
| High | 15.02 on 04/28/25 | 42.54 on 04/30/25 | 16.84 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | -14.47% since 03/28/25 | +5.57% since 03/28/25 | +12.65% since 03/28/25 | ||
| Low | 13.40 on 04/09/25 | 31.42 on 04/09/25 | 10.57 on 04/07/25 | ||
| High | 16.88 on 03/31/25 | 42.54 on 04/30/25 | 16.84 on 04/30/25 | ||
| 3-Month | |||||
| %Chg | -21.88% since 01/30/25 | -10.70% since 01/30/25 | -29.39% since 01/30/25 | ||
| Low | 13.40 on 04/09/25 | 31.42 on 04/09/25 | 10.57 on 04/07/25 | ||
| High | 20.68 on 02/21/25 | 48.54 on 02/07/25 | 24.34 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | -1.15% since 10/30/24 | -10.47% since 10/30/24 | -37.99% since 10/30/24 | ||
| Low | 13.40 on 04/09/25 | 31.42 on 04/09/25 | 10.57 on 04/07/25 | ||
| High | 20.68 on 02/21/25 | 58.26 on 12/17/24 | 33.33 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,414,615 | 2,572,002 | 2,396,493 | ||
| Shares Outstanding, K | 167,333 | 64,012 | 145,242 | ||
| Annual Sales | 957,800,000 | 0 | 0 | ||
| Annual Net Income | 226,450,000 | -118,940,000 | -422,770,000 | ||
| Last Quarter Sales | 259,600,000 | 0 | 0 | ||
| Last Quarter Net Income | 143,740,000 | -45,600,000 | -114,750,000 | ||
| 60-Month Beta | 0.54 | 1.32 | 1.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.17 on 02/26/25 | -0.72 on 02/26/25 | -0.67 on 02/27/25 | ||
| Latest Earnings Date | 05/07/25 | 05/06/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 21.88 | 0.00 | 0.00 | ||